8-K Announcements
6Material company update
Apr 30, 2026·SEC
Material company update
Apr 2, 2026·SEC
Material company update
Feb 24, 2026·SEC
Option Care Health, Inc.(OPCH)Earnings, Financials & Key Ratios
OPCH•NASDAQ
17.3× P/E·Price updated Jun 19, 2026
AboutOption Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.Show more
- Revenue$5.65B+13.0%
- EBITDA$409M+6.0%
- Net Income$208M-2.0%
- EPS (Diluted)1.27+3.3%
- Gross Margin18.06%-10.9%
- EBITDA Margin7.23%-6.2%
- Operating Margin5.98%-7.1%
- Net Margin3.67%-13.3%
- ROE15.2%+1.4%
OPCH Key Insights
Option Care Health, Inc. (OPCH) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 13.3%
- ✓Good 3Y average ROE of 16.4%
- ✓Share count reduced 5.5% through buybacks
- ✓Efficient asset utilization: 1.6x turnover
✗Weaknesses
- ✗Weak momentum: RS Rating 17 (bottom 17%)
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when OPCH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
OPCH Price & Volume
Option Care Health, Inc. (OPCH) stock price & volume — 10-year historical chart
Loading chart...
OPCH Growth Metrics
Option Care Health, Inc. (OPCH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years19.12%
5 Years13.25%
3 Years12.72%
TTM9.3%
Profit CAGR
10 Years-
5 Years-
3 Years11.3%
TTM-3.55%
EPS CAGR
10 Years-
5 Years-
3 Years15.23%
TTM4.03%
Return on Capital
10 Years4.52%
5 Years10.77%
3 Years12.19%
Last Year12.83%
OPCH Recent Earnings
Option Care Health, Inc. (OPCH) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
Apr 30, 2026Metric
Actual
Est
EPS
$0.40+8.1%
$0.37
Rev
$1.4B-2.8%
$1.4B
Q1 2026
Feb 24, 2026Metric
Actual
Est
EPS
$0.46+0.0%
$0.46
Rev
$1.5B+0.3%
$1.5B
Q4 2025
Oct 30, 2025Metric
Actual
Est
EPS
$0.45+4.7%
$0.43
Rev
$1.4B-1.9%
$1.5B
Q3 2025
Jul 30, 2025Metric
Actual
Est
EPS
$0.41+2.5%
$0.40
Rev
$1.4B+1.0%
$1.4B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 30, 2026 | $0.40vs $0.37+8.1% | $1.4Bvs $1.4B-2.8% |
| Q1 2026 | Feb 24, 2026 | $0.46vs $0.46+0.0% | $1.5Bvs $1.5B+0.3% |
| Q4 2025 | Oct 30, 2025 | $0.45vs $0.43+4.7% | $1.4Bvs $1.5B-1.9% |
| Q3 2025 | Jul 30, 2025 | $0.41vs $0.40+2.5% | $1.4Bvs $1.4B+1.0% |
Based on last 12 quarters of dataView full earnings history →
OPCH Peer Comparison
Option Care Health, Inc. (OPCH) competitors in Home-based care services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 PNTG | 1.16B | 33.44 | 39.81 | 36.31% | 2.96% | 8.42% | 1.21 | |
 EHAB | 706.91M | 13.80 | -152.32 | 2.44% | -0.3% | -0.55% | 0.89 | |
 ACHC | 2.29B | 24.87 | -2.05 | 5.04% | -32.84% | -40.92% | 1.24 | |
 HCSG | 1.64B | 22.94 | 28.32 | 7.08% | 3.21% | 11.83% | 0.05 | |
 SGRY | 1.9B | 14.55 | -23.85 | 6.24% | -2.28% | -2.15% | 1.14 | |
 INNV | 1.22B | 8.97 | -40.77 | 11.76% | -2.35% | -8.18% | 0.38 | |
 CVS | 125.45B | 98.32 | 70.73 | 7.85% | 0.72% | 3.86% | 1.24 | |
 MCK | 90.23B | 750.63 | 19.56 | 12.36% | 1.18% |
Compare OPCH vs Peers
Option Care Health, Inc. (OPCH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
OPCH Income Statement
Option Care Health, Inc. (OPCH) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 817.19M | 1.94B | 2.31B | 3.03B | 3.44B | 3.94B | 4.3B | 5B | 5.65B | 5.67B |
Revenue Growth % | -12.65% | 137.37% | 19.11% | 31.26% | 13.39% | 14.72% | 9.06% | 16.17% | 13.03% | 9.3% |
Cost of Goods Sold | 547.95M | 1.52B | 1.8B | 2.35B | 2.66B | 3.08B | 3.32B | 3.99B | 4.63B | 4.65B |
COGS % of Revenue | 67.05% | 78.23% | 77.8% | 77.5% | 77.33% | 78.02% | 77.19% | 79.73% | 81.94% | - |
Gross Profit | 269.24M▲ 0% | 422.21M▲ 56.8% | 513M▲ 21.5% | 682.26M▲ 33.0% | 779.61M▲ 14.3% | 866.92M▲ 11.2% | 981.22M▲ 13.2% | 1.01B▲ 3.2% | 1.02B▲ 0.7% | 1.02B▲ 0% |
Gross Margin % | 32.95% | 21.77% | 22.2% | 22.5% | 22.67% | 21.98% | 22.81% | 20.27% | 18.06% | 18% |
Gross Profit Growth % | 2.73% | 56.82% | 21.5% | 33% | 14.27% | 11.2% | 13.19% | 3.24% | 0.73% | - |
Operating Expenses | 332.55M | 383.95M | 513.32M | 571.51M | 588.76M | 626.69M | 666.63M | 691.16M | 682.45M | 684.29M |
OpEx % of Revenue | 40.69% | 19.79% | 22.22% | 18.85% | 17.12% | 15.89% | 15.49% | 13.83% | 12.08% | - |
Selling, General & Admin | 39.63M | 345.88M | 459.63M | 500.2M | 525.71M | 566.12M | 607.43M | 630.25M | 682.45M | 684.29M |
SG&A % of Revenue | 4.85% | 17.83% | 19.89% | 16.49% | 15.29% | 14.35% | 14.12% | 12.61% | 12.08% | - |
Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
Other Operating Expenses | 292.92M | 38.06M | 53.69M | 71.31M | 63.06M | 60.56M | 59.2M | 60.91M | 0 | 0 |
Operating Income | -63.3M▲ 0% | 38.27M▲ 160.5% | -319K▼ 100.8% | 110.75M▲ 34819.4% | 190.84M▲ 72.3% | 240.23M▲ 25.9% | 314.6M▲ 31.0% | 321.83M▲ 2.3% | 337.91M▲ 5.0% | 335.87M▲ 0% |
Operating Margin % | -7.75% | 1.97% | -0.01% | 3.65% | 5.55% | 6.09% | 7.31% | 6.44% | 5.98% | 5.93% |
Operating Income Growth % | -75.01% | 160.45% | -100.83% | 34819.44% | 72.31% | 25.88% | 30.96% | 2.3% | 4.99% | - |
EBITDA | -35.58M | 79.32M | 57.55M | 188.65M | 259.64M | 305.67M | 376.8M | 385.33M | 408.6M | 405.84M |
EBITDA Margin % | -4.35% | 4.09% | 2.49% | 6.22% | 7.55% | 7.75% | 8.76% | 7.71% | 7.23% | 7.16% |
EBITDA Growth % | -151.49% | 322.96% | -27.45% | 227.8% | 37.63% | 17.72% | 23.27% | 2.27% | 6.04% | 2.34% |
D&A (Non-Cash Add-back) | 27.73M | 41.05M | 57.87M | 77.9M | 68.8M | 65.43M | 62.2M | 63.5M | 70.69M | 69.97M |
EBIT | 38.62M | 37.06M | -4.47M | 102.53M | 183.5M | 259.57M | 409.99M | 332.63M | 337.91M | 335.87M |
Net Interest Income | -52.07M | -46.12M | -73.39M | -91.19M | -55.46M | -54.9M | -62.22M | -60.56M | -63.2M | -61.08M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 52.07M | 46.12M | 73.39M | 91.19M | 55.46M | 54.9M | 62.22M | 60.56M | 63.2M | 61.08M |
Other Income/Expense | -4.13M | -47.04M | -77.88M | -116M | -74.35M | -34.46M | 44.15M | -38.23M | -55.01M | -55.52M |
Pretax Income | -67.43M▲ 0% | -8.77M▲ 87.0% | -78.19M▼ 791.8% | -5.24M▲ 93.3% | 116.49M▲ 2321.9% | 205.77M▲ 76.6% | 358.74M▲ 74.3% | 283.6M▼ 20.9% | 282.9M▼ 0.2% | 280.35M▲ 0% |
Pretax Margin % | -8.25% | -0.45% | -3.38% | -0.17% | 3.39% | 5.22% | 8.34% | 5.67% | 5.01% | 4.95% |
Income Tax | -4.13M | -2.65M | -2.27M | 2.83M | -23.4M | 55.21M | 91.65M | 71.78M | 75.31M | 74.16M |
Effective Tax Rate % | 6.12% | 30.26% | 2.91% | -54.03% | -20.09% | 26.83% | 25.55% | 25.31% | 26.62% | 26.45% |
Net Income | -64.2M▲ 0% | -6.12M▲ 90.5% | -75.92M▼ 1141.5% | -8.08M▲ 89.4% | 139.9M▲ 1832.3% | 150.56M▲ 7.6% | 267.09M▲ 77.4% | 211.82M▼ 20.7% | 207.59M▼ 2.0% | 206.19M▲ 0% |
Net Margin % | -7.86% | -0.32% | -3.29% | -0.27% | 4.07% | 3.82% | 6.21% | 4.24% | 3.67% | 3.64% |
Net Income Growth % | -50.11% | 90.47% | -1141.54% | 89.36% | 1832.27% | 7.62% | 77.4% | -20.69% | -2% | -3.55% |
Net Income (Continuing) | -63.3M | -6.12M | -75.92M | -8.08M | 139.9M | 150.56M | 267.09M | 211.82M | 207.59M | 206.19M |
Discontinued Operations | -893K | -101K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -2.02▲ 0% | -1.62▲ 19.8% | -0.49▲ 69.8% | -0.04▲ 90.9% | 0.77▲ 1826.5% | 0.83▲ 7.8% | 1.48▲ 78.3% | 1.23▼ 16.9% | 1.27▲ 3.3% | 1.30▲ 0% |
EPS Growth % | -14.12% | 19.8% | 69.75% | 90.9% | 1826.46% | 7.79% | 78.31% | -16.89% | 3.25% | 4.03% |
EPS (Basic) | -2.02 | -1.62 | -0.49 | -0.04 | 0.78 | 0.83 | 1.49 | 1.23 | 1.28 | - |
Diluted Shares Outstanding | 30.95M | 31.99M | 156.28M | 180.97M | 181.21M | 182.07M | 180.38M | 172.84M | 163.37M | 158.21M |
Basic Shares Outstanding | 30.95M | 31.99M | 156.28M | 180.97M | 179.85M | 181.1M | 178.97M | 171.57M | 162.1M | 156.65M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
OPCH Balance Sheet
Option Care Health, Inc. (OPCH) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 189.32M | 174.71M | 558.65M | 657.01M | 710.26M | 994.34M | 1.09B | 1.32B | 1.26B | 1.2B |
Cash & Short-Term Investments | 39.46M | 14.54M | 67.06M | 99.27M | 119.42M | 294.19M | 343.85M | 412.56M | 232.62M | 177.32M |
Cash Only | 39.46M | 14.54M | 67.06M | 99.27M | 119.42M | 294.19M | 343.85M | 412.56M | 232.62M | 177.32M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 85.52M | 114.86M | 324.42M | 330.74M | 338.24M | 383.14M | 430.16M | 409.73M | 473.57M | 516.44M |
Days Sales Outstanding | 38.2 | 21.61 | 51.25 | 39.81 | 35.9 | 35.45 | 36.49 | 29.92 | 30.6 | 31.33 |
Inventory | 37.27M | 26.69M | 115.88M | 158.6M | 183.09M | 224.28M | 274M | 388.13M | 471.15M | 415.69M |
Days Inventory Outstanding | 24.83 | 6.42 | 23.53 | 24.63 | 25.13 | 26.6 | 30.11 | 35.55 | 37.15 | 33.5 |
Other Current Assets | 4.95M | 4.32M | 13.9M | 68.41M | 69.5M | 92.73M | 46.24M | 112.2M | 87.63M | 85.66M |
Total Non-Current Assets | 416.56M | 409.23M | 2.03B | 2.12B | 2.22B | 2.24B | 2.23B | 2.1B | 2.19B | 2.18B |
Property, Plant & Equipment | 27.57M | 28.79M | 133.2M | 189.94M | 186.31M | 180.75M | 204.79M | 213.9M | 139.24M | 139.94M |
Fixed Asset Turnover | 29.64x | 67.38x | 17.35x | 15.97x | 18.46x | 21.82x | 21.01x | 23.37x | 40.58x | 41.43x |
Goodwill | 367.2M | 367.2M | 1.43B | 1.43B | 1.48B | 1.53B | 1.54B | 1.54B | 1.61B | 1.61B |
Intangible Assets | 19.5M | 10.47M | 385.91M | 351.05M | 366.02M | 364.12M | 335.4M | 16.99M | 21.9M | 21.06M |
Long-Term Investments | 0 | 14.6M | -2.14M | 17M | 20.1M | 36.74M | 31.08M | 31.18M | 0 | 28.23M |
Other Non-Current Assets | 2.29M | -12.86M | 86.24M | 3.82M | 3.63M | 3.57M | 11.27M | 296.8M | 422.93M | 417.25M |
Total Assets | 605.88M▲ 0% | 583.94M▼ 3.6% | 2.59B▲ 343.5% | 2.77B▲ 7.1% | 2.93B▲ 5.5% | 3.23B▲ 10.5% | 3.33B▲ 3.0% | 3.42B▲ 2.8% | 3.46B▲ 1.0% | 3.38B▲ 0% |
Asset Turnover | 1.35x | 3.32x | 0.89x | 1.09x | 1.18x | 1.22x | 1.29x | 1.46x | 1.63x | 1.65x |
Asset Growth % | -0.31% | -3.62% | 343.46% | 7.07% | 5.52% | 10.48% | 2.97% | 2.81% | 0.99% | 5.7% |
Total Current Liabilities | 105.47M | 107.32M | 330M | 434.02M | 459.69M | 565.35M | 618.31M | 780.15M | 829.35M | 729.75M |
Accounts Payable | 65.96M | 67.03M | 221.06M | 282.91M | 279.25M | 378.76M | 426.51M | 610.78M | 639.83M | 545.02M |
Days Payables Outstanding | 43.94 | 16.12 | 44.89 | 43.94 | 38.33 | 44.92 | 46.88 | 55.94 | 50.45 | 47.18 |
Short-Term Debt | 1.72M | 3.18M | 29.64M | 28.14M | 25.09M | 25.38M | 24.28M | 6.51M | 0 | 0 |
Deferred Revenue (Current) | 8.86M | 0 | 2.14M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 23.23M | 64.08M | 71.86M | 84.3M | 75.01M | 140.81M | 189.52M | 184.73M |
Current Ratio | 1.79x | 1.63x | 1.69x | 1.51x | 1.55x | 1.76x | 1.77x | 1.70x | 1.53x | 1.64x |
Quick Ratio | 1.44x | 1.38x | 1.34x | 1.15x | 1.15x | 1.36x | 1.33x | 1.20x | 0.96x | 1.07x |
Cash Conversion Cycle | 19.09 | 11.91 | 29.89 | 20.5 | 22.7 | 17.13 | 19.73 | 9.53 | 17.3 | 17.65 |
Total Non-Current Liabilities | 581.51M | 620.63M | 1.35B | 1.32B | 1.29B | 1.28B | 1.29B | 1.24B | 1.3B | 1.3B |
Long-Term Debt | 478.87M | 501.5M | 1.28B | 1.12B | 1.06B | 1.06B | 1.06B | 1.1B | 0 | 0 |
Capital Lease Obligations | 0 | 0 | 58.24M | 70.78M | 74.49M | 71.44M | 85.48M | 84.78M | 0 | 186.07M |
Deferred Tax Liabilities | 0 | 67.84M | 2.14M | 128.56M | 134.72M | 141.6M | 146.24M | 47.58M | 0 | 99.23M |
Other Non-Current Liabilities | 102.65M | 119.13M | 17.23M | 8.47M | 20.94M | 9.68M | 0 | 366K | 1.3B | 1.3B |
Total Liabilities | 686.99M | 727.94M | 1.68B | 1.76B | 1.75B | 1.85B | 1.91B | 2.02B | 2.13B | 2.03B |
Total Debt | 480.59M | 504.67M | 1.39B | 1.21B | 1.16B | 1.16B | 1.17B | 1.22B | 0 | 0 |
Net Debt | 441.13M | 490.13M | 1.32B | 1.11B | 1.04B | 860.84M | 822.56M | 805.41M | -232.62M | -177.32M |
Debt / Equity | - | - | 1.53x | 1.20x | 0.99x | 0.83x | 0.82x | 0.87x | - | 0.00x |
Debt / EBITDA | - | 6.36x | 24.08x | 6.44x | 4.47x | 3.78x | 3.10x | 3.16x | - | 0.00x |
Net Debt / EBITDA | - | 6.18x | 22.91x | 5.91x | 4.01x | 2.82x | 2.18x | 2.09x | -0.57x | -0.44x |
Interest Coverage | 0.74x | 0.80x | -0.06x | 1.12x | 3.31x | 4.73x | 6.59x | 5.49x | 5.35x | 5.50x |
Total Equity | -81.1M▲ 0% | -144M▼ 77.6% | 906.83M▲ 729.7% | 1.02B▲ 12.0% | 1.18B▲ 15.8% | 1.39B▲ 17.9% | 1.42B▲ 2.6% | 1.4B▼ 1.2% | 1.33B▼ 5.5% | 1.35B▲ 0% |
Equity Growth % | -156.96% | -77.56% | 729.72% | 12.01% | 15.77% | 17.88% | 2.57% | -1.23% | -5.54% | -13.91% |
Book Value per Share | -2.62 | -4.50 | 5.80 | 5.61 | 6.49 | 7.61 | 7.88 | 8.12 | 8.12 | 8.54 |
Total Shareholders' Equity | -81.1M | -144M | 906.83M | 1.02B | 1.18B | 1.39B | 1.42B | 1.4B | 1.33B | 1.35B |
Common Stock | 13K | 13K | 18K | 18K | 18K | 18K | 18K | 18K | 0 | 0 |
Retained Earnings | -706.02M | -761.2M | -91.95M | -100.03M | 39.87M | 190.42M | 457.51M | 669.34M | 0 | 0 |
Treasury Stock | 0 | -950K | -2.4M | -2.4M | -2.4M | -2.4M | -255.11M | -507.6M | 0 | 0 |
Accumulated OCI | -88.3M | 1M | -7.2M | -11.17M | -451K | 21.16M | 14.98M | 11.05M | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
OPCH Cash Flow Statement
Option Care Health, Inc. (OPCH) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -1.05M | -20.1M | 39.47M | 127.39M | 208.57M | 267.55M | 371.3M | 323.39M | 258.45M | 253.55M |
Operating CF Margin % | -0.13% | -1.04% | 1.71% | 4.2% | 6.07% | 6.78% | 8.63% | 6.47% | 4.57% | - |
Operating CF Growth % | 97.01% | -1811.03% | 296.31% | 222.78% | 63.72% | 28.28% | 38.78% | -12.9% | -20.08% | -135.41% |
Net Income | -61.28M | -51.59M | -75.92M | -8.08M | 139.9M | 150.56M | 267.09M | 211.82M | 207.59M | 206.19M |
Depreciation & Amortization | 26.31M | 23.6M | 57.87M | 77.9M | 68.8M | 65.43M | 62.2M | 63.5M | 70.69M | 69.97M |
Stock-Based Compensation | 2.36M | 4.17M | 4.17M | 2.92M | 9.57M | 16.78M | 30.48M | 36.14M | 39.96M | -232K |
Deferred Taxes | -3.15M | 66K | -4.61M | 1.2M | -30.37M | 49.19M | 12.77M | 12.66M | 8.44M | 0 |
Other Non-Cash Items | 17.01M | 20.35M | 19.38M | 46.33M | 32.03M | 15.36M | 20.2M | 19.52M | 31.52M | -10.6M |
Working Capital Changes | 17.71M | -16.71M | 38.58M | 7.13M | -11.37M | -29.78M | -21.45M | -20.25M | -99.75M | -11.78M |
Change in Receivables | 23.56M | -29.34M | 82.28M | -3.92M | -4.27M | -36.89M | 224K | -32.08M | -54.59M | -40.67M |
Change in Inventory | -1.77M | 11.36M | -12.85M | -42.73M | -22.7M | -41.01M | -51M | -114.13M | -81.47M | -47.8M |
Change in Payables | -2.54M | 1.06M | -30.86M | 59.22M | -10.38M | 98.89M | 47.7M | 183.4M | 19.52M | 14.38M |
Cash from Investing | -13.34M | -13.52M | -727.83M | -26.33M | -111.54M | -108.05M | -56.51M | -36.47M | -161.08M | -43.71M |
Capital Expenditures | -8.39M | -13.88M | -28.29M | -26.88M | -25.63M | -35.36M | -41.87M | 0 | -41.31M | -9.1M |
CapEx % of Revenue | 1.03% | 0.72% | 1.22% | 0.89% | 0.75% | 0.9% | 0.97% | 0.71% | 0.73% | 0.16% |
Acquisitions | 0 | 360K | -700.17M | 0 | -85.91M | -87.36M | -12.49M | 0 | -117.25M | 75K |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -4.95M | 360K | 636K | 541K | 0 | 14.67M | -2.15M | -36.47M | -2.53M | -34.69M |
Cash from Financing | 44.28M | 8.07M | 719.02M | -68.85M | -76.87M | 15.27M | -265.13M | -218.21M | -277.31M | -203.89M |
Debt Issued (Net) | 23.38M | -4.15M | 752.24M | -183.25M | -76.84M | -6M | -6M | 43.58M | 40.9M | 49.16M |
Equity Issued (Net) | 20.78M | 0 | 0 | 118.93M | -32K | 0 | -250.26M | -252.73M | -309.95M | -209.73M |
Dividends Paid | 0 | 0 | -2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | -2.5M | 0 | -32K | 0 | -250.26M | -252.73M | -309.95M | -227.27M |
Other Financing | 120K | 0 | -31.21M | -4.53M | 0 | 21.27M | -8.87M | -9.05M | -8.25M | -43.33M |
Net Change in Cash | 29.89M▲ 0% | -25.55M▼ 185.5% | 30.66M▲ 220.0% | 32.21M▲ 5.0% | 20.16M▼ 37.4% | 174.76M▲ 767.0% | 49.66M▼ 71.6% | 68.72M▲ 38.4% | -179.94M▼ 361.9% | 5.95M▲ 0% |
Free Cash Flow | -9.44M▲ 0% | -33.98M▼ 259.9% | 11.18M▲ 132.9% | 100.52M▲ 799.5% | 182.94M▲ 82.0% | 232.19M▲ 26.9% | 329.43M▲ 41.9% | 287.79M▼ 12.6% | 258.45M▼ 10.2% | 244.46M▲ 0% |
FCF Margin % | -1.16% | -1.75% | 0.48% | 3.31% | 5.32% | 5.89% | 7.66% | 5.76% | 4.57% | 4.31% |
FCF Growth % | 78.95% | -259.87% | 132.89% | 799.48% | 82% | 26.92% | 41.88% | -12.64% | -10.19% | -29.31% |
FCF per Share | -0.31 | -1.06 | 0.07 | 0.56 | 1.01 | 1.28 | 1.83 | 1.66 | 1.58 | 1.55 |
FCF Conversion (FCF/Net Income) | 0.02x | 3.29x | -0.52x | -15.77x | 1.49x | 1.78x | 1.39x | 1.53x | 1.25x | 1.19x |
Interest Paid | 45.38M | 47.17M | 50.81M | 97.64M | 60.92M | 50.37M | 69.8M | 71.55M | 0 | 21.76M |
Taxes Paid | 649K | 1.6M | 2.4M | 2.88M | 5.71M | 13.44M | 75.24M | 64.52M | 0 | 38.6M |
OPCH Key Ratios
Option Care Health, Inc. (OPCH) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | - | - | -19.91% | -0.84% | 12.77% | 11.75% | 19.02% | 14.99% | 15.2% | 15.28% |
Return on Invested Capital (ROIC) | -12.32% | 8.13% | -0.02% | 3.81% | 6.59% | 8.07% | 10.51% | 10.84% | 15.34% | 14.43% |
Gross Margin | 32.95% | 21.77% | 22.2% | 22.5% | 22.67% | 21.98% | 22.81% | 20.27% | 18.06% | 18% |
Net Margin | -7.86% | -0.32% | -3.29% | -0.27% | 4.07% | 3.82% | 6.21% | 4.24% | 3.67% | 3.64% |
Debt / Equity | - | - | 1.53x | 1.20x | 0.99x | 0.83x | 0.82x | 0.87x | - | 0.00x |
Interest Coverage | 0.74x | 0.80x | -0.06x | 1.12x | 3.31x | 4.73x | 6.59x | 5.49x | 5.35x | 5.50x |
FCF Conversion | 0.02x | 3.29x | -0.52x | -15.77x | 1.49x | 1.78x | 1.39x | 1.53x | 1.25x | 1.19x |
Revenue Growth | -12.65% | 137.37% | 19.11% | 31.26% | 13.39% | 14.72% | 9.06% | 16.17% | 13.03% | 9.3% |
Related:OPCH Dividend History·OPCH Revenue History·OPCH Price History·OPCH P/E History·OPCH Financial Ratios·OPCH Institutional Holders
OPCH SEC Filings & Documents
Option Care Health, Inc. (OPCH) SEC filings — annual & quarterly reports (10-K, 10-Q)
OPCH Frequently Asked Questions
Option Care Health, Inc. (OPCH) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Option Care Health, Inc. (OPCH) reported $5.67B in revenue for fiscal year 2025. This represents a 1901% increase from $283.2M in 1996.
Option Care Health, Inc. (OPCH) grew revenue by 13.0% over the past year. This is steady growth.
Yes, Option Care Health, Inc. (OPCH) is profitable, generating $206.2M in net income for fiscal year 2025 (3.7% net margin).
Dividend & Returns
Option Care Health, Inc. (OPCH) has a return on equity (ROE) of 15.2%. This is reasonable for most industries.
Option Care Health, Inc. (OPCH) generated $244.5M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.